Clinical Impact of New Rheumatoid Arthritis Findings From EULAR 2020*

My take on the most important findings in RA prevention and treatment presented at the virtual EULAR 2020 E-Congress.

Paul Emery, MA, MD, FRCP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: July 16, 2020 Expired: No longer available for credit

My take on the most important findings regarding efficacy and safety of JAK inhibitors in RA presented at the virtual EULAR 2020 E-Congress.

Eric M. Ruderman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: July 16, 2020 Expired: No longer available for credit

My thoughts on recent studies of RA and ILD, fatigue, and cancer presented at the virtual EULAR 2020 E-Congress.

Paul Emery, MA, MD, FRCP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: August 24, 2020 Expired: No longer available for credit

What to do in biologic-experienced patients with RA? Here’s my take.

Eric M. Ruderman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: August 27, 2020 Expired: No longer available for credit